X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs ALEMBIC PHARMA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA ALEMBIC PHARMA FULFORD INDIA/
ALEMBIC PHARMA
 
P/E (TTM) x 398.8 23.4 1,706.2% View Chart
P/BV x 6.2 6.1 101.2% View Chart
Dividend Yield % 0.1 0.8 11.0%  

Financials

 FULFORD INDIA   ALEMBIC PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
ALEMBIC PHARMA
Mar-16
FULFORD INDIA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs942792 119.0%   
Low Rs450443 101.6%   
Sales per share (Unadj.) Rs691.4167.0 413.9%  
Earnings per share (Unadj.) Rs11.538.2 30.0%  
Cash flow per share (Unadj.) Rs15.442.0 36.6%  
Dividends per share (Unadj.) Rs2.004.00 50.0%  
Dividend yield (eoy) %0.30.6 44.3%  
Book value per share (Unadj.) Rs380.084.9 447.6%  
Shares outstanding (eoy) m3.90188.52 2.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.7 27.2%   
Avg P/E ratio x60.716.2 375.4%  
P/CF ratio (eoy) x45.314.7 308.2%  
Price / Book Value ratio x1.87.3 25.2%  
Dividend payout %17.410.5 166.5%   
Avg Mkt Cap Rs m2,714116,383 2.3%   
No. of employees `0000.4NA-   
Total wages/salary Rs m5054,214 12.0%   
Avg. sales/employee Rs Th6,073.0NM-  
Avg. wages/employee Rs Th1,137.4NM-  
Avg. net profit/employee Rs Th100.7NM-  
INCOME DATA
Net Sales Rs m2,69631,487 8.6%  
Other income Rs m12555 227.6%   
Total revenues Rs m2,82231,542 8.9%   
Gross profit Rs m-4610,060 -0.5%  
Depreciation Rs m15722 2.1%   
Interest Rs m1037 25.8%   
Profit before tax Rs m549,356 0.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m102,160 0.4%   
Profit after tax Rs m457,194 0.6%  
Gross profit margin %-1.731.9 -5.4%  
Effective tax rate %17.723.1 76.6%   
Net profit margin %1.722.8 7.3%  
BALANCE SHEET DATA
Current assets Rs m1,73815,066 11.5%   
Current liabilities Rs m5457,674 7.1%   
Net working cap to sales %44.323.5 188.6%  
Current ratio x3.22.0 162.6%  
Inventory Days Days4867 72.4%  
Debtors Days Days441 10.6%  
Net fixed assets Rs m128,237 0.1%   
Share capital Rs m39377 10.3%   
"Free" reserves Rs m1,44315,416 9.4%   
Net worth Rs m1,48216,005 9.3%   
Long term debt Rs m00-   
Total assets Rs m2,07724,594 8.4%  
Interest coverage x6.7255.2 2.6%   
Debt to equity ratio x00-  
Sales to assets ratio x1.31.3 101.4%   
Return on assets %2.629.4 8.9%  
Return on equity %3.044.9 6.7%  
Return on capital %4.358.7 7.3%  
Exports to sales %055.7 0.0%   
Imports to sales %24.510.4 234.5%   
Exports (fob) Rs mNA17,551 0.0%   
Imports (cif) Rs m6593,283 20.1%   
Fx inflow Rs m1717,811 0.1%   
Fx outflow Rs m6735,318 12.7%   
Net fx Rs m-65612,493 -5.3%   
CASH FLOW
From Operations Rs m909,304 1.0%  
From Investments Rs m105-3,105 -3.4%  
From Financial Activity Rs m-14-1,959 0.7%  
Net Cashflow Rs m1814,240 4.3%  

Share Holding

Indian Promoters % 0.0 74.1 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 2.9 131.0%  
FIIs % 0.1 9.1 1.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 13.9 152.5%  
Shareholders   4,783 49,328 9.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   JUBILANT LIFE SCIENCES  PANACEA BIOTECH  WOCKHARDT LTD.  VENUS REMEDIES  WYETH LTD  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS